Übersicht

Olaf Witt’s major interest is the identification of biomarkers for response prediction in precision medicine as well as in developing rationale treatment combination strategies to overcome resistance in pediatric oncology. Currently, Olaf Witt is coordinating the (inter)national precision program in pediatric oncology termed “INFORM” (INdividualized Therapy FOr Relapsed Malignancies in Childhood) since 2015 and is developing innovative phase I/II biomarker driven combination trials in pediatric oncology.